» Articles » PMID: 3958492

Origin and Differentiation of Natural Killer Cells. II. Functional and Morphologic Studies of Purified NK-1.1+ Cells

Overview
Journal J Immunol
Date 1986 Apr 15
PMID 3958492
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Cells bearing the NK-specific marker NK-1.1 were purified from mouse spleens by utilizing a monoclonal anti-NK-1.1 antibody and cell sorting. In normal adult mice, all of the splenic NK activity against YAC-1 cells was found in the NK-1.1+ fraction, whereas NK-1.1- cells were depleted of NK activity. The NK activity of sorted NK-1.1+ cells was enriched 15- to 30-fold over unfractionated spleen cells. Light and electron microscopic studies of purified NK-1.1+ cells showed a homogeneous population of cells, each containing one to four cytoplasmic granules. Mice whose bone marrow has been destroyed by chronic exposure to 17-beta-estradiol have very low NK activity. However, spleen cells of estradiol-treated mice contained a normal frequency of NK-1.1+ cells which bound to YAC-1 cells, but failed to lyse them even after purification and subsequent exposure to interferon-alpha/beta in vitro. It appears, therefore, that in the absence of intact bone marrow, NK-1.1+ cells may be arrested in a nonlytic and interferon-unresponsive state. Spleens of neonatal mice which have low NK activity were analyzed to ascertain whether immature NK-1.1+ cells, similar to those found in estradiol-treated mice, could be demonstrated. Spleens of 8- to 9-day-old mice also contained NK-1.1+ cells which had very low NK activity even after purification. Sorted NK-1.1+ cells were examined for cytotoxicity in mice whose NK activity was suppressed by pretreatment with Corynebacterium parvum (-15 days). In contrast to cells from estradiol-treated and neonatal mice, NK-1.1+ from mice treated with C. parvum had normal functional activity. Similarly, although NK activity of unfractionated bone marrow cells is low, sorted NK-1.1+ cells were greatly enriched for lytic activity. Thus, we conclude that cell sorting with monoclonal anti-NK-1.1 antibody provides a powerful tool for examining the mechanisms underlying various states of low NK activity, and there exist NK-1.1+, nonlytic, interferon-unresponsive cells which apparently require an intact marrow microenvironment for differentiation into mature, lytic NK cells.

Citing Articles

Suppressing NK Cells by Astragaloside IV Protects Against Acute Ischemic Stroke in Mice Inhibiting STAT3.

Li S, Dou B, Shu S, Wei L, Zhu S, Ke Z Front Pharmacol. 2022; 12:802047.

PMID: 35185544 PMC: 8852846. DOI: 10.3389/fphar.2021.802047.


Comparison of the purity and vitality of natural killer cells with different isolation kits.

Wang G, Yu G, Wang D, Guo S, Shan F Exp Ther Med. 2017; 13(5):1875-1883.

PMID: 28565780 PMC: 5443303. DOI: 10.3892/etm.2017.4189.


Complexity and Diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition Systems.

Kirkham C, Carlyle J Front Immunol. 2014; 5:214.

PMID: 24917862 PMC: 4041007. DOI: 10.3389/fimmu.2014.00214.


Ischemic neurons recruit natural killer cells that accelerate brain infarction.

Gan Y, Liu Q, Wu W, Yin J, Bai X, Shen R Proc Natl Acad Sci U S A. 2014; 111(7):2704-9.

PMID: 24550298 PMC: 3932858. DOI: 10.1073/pnas.1315943111.


NKR-P1 biology: from prototype to missing self.

Mesci A, Ljutic B, Makrigiannis A, Carlyle J Immunol Res. 2006; 35(1-2):13-26.

PMID: 17003506 DOI: 10.1385/IR:35:1:13.